𝛼SK or Search

ENTITY

BeOne (ONC US)

187

Analysis

Health Care • China

BeiGene, Ltd. operates as a commercial stage biopharmaceutical company. The Company focuses on discovery, development, and commercialization of molecularly targeted and immuno-oncology drugs for the treatment of cancer. BeiGene serves patients worldwide.

more

Refresh

Exchange Announcement • 26 Aug 2026 18:14

Current Report (Form 8-K | Period ending 2026-08-26)

Exchange Announcement • 05 Aug 2026 18:04

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 05 Aug 2026 18:02

Current Report (Form 8-K | Period ending 2026-08-05)

Exchange Announcement • 26 Jun 2026 18:02

Current Report (Form 8-K | Period ending 2026-06-26)

Exchange Announcement • 12 Jun 2026 04:55

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x